Related Experiment Video
Updated: Feb 7, 2026

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
Vaccinia-related kinase 2 modulates role of dysbindin by regulating protein stability
Young-Hun Jeong1, Jung-Hyun Choi1, Dohyun Lee1,2
1Department of Life Sciences, Pohang University of Science and Technology, Pohang, Korea.
Abstract:
Vaccinia-related kinase 2 (VRK2) is a serine/threonine kinase that belongs to the casein kinase 1 family. VRK2 has long been known for its relationship with neurodegenerative disorders such as schizophrenia. However, the role of VRK2 and the substrates associated with it are unknown. Dysbindin is known as one of the strong risk factors for schizophrenia. The expression of dysbindin is indeed significantly reduced in schizophrenia patients. Moreover, dysbindin is involved in neurite outgrowth and regulation of NMDA receptor signaling. Here, we first identified dysbindin as a novel interacting protein of VRK2 through immunoprecipitation. We hypothesized that dysbindin is phosphorylated by VRK2 and further that this phosphorylation plays an important role in the function of dysbindin. We show that VRK2 phosphorylates Ser 297 and Ser 299 of dysbindin using in vitro kinase assay. In addition, we found that VRK2-mediated phosphorylation of dysbindin enhanced ubiquitination of dysbindin and consequently resulted in the decrease in its protein stability through western blotting. Over-expression of VRK2 in human neuroblastoma (SH-SY5Y) cells reduced neurite outgrowth induced by retinoic acid. Furthermore, a phosphomimetic mutant of dysbindin alleviated neurite outgrowth and affected surface expression of N-methyl-d-aspartate 2A, a subunit of NMDA receptor in mouse hippocampal neurons. Together, our work reveals the regulation of dysbindin by VRK2, providing the association of these two proteins, which are commonly implicated in schizophrenia. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
Insights
Vaccinia-related kinase 2 (VRK2) phosphorylates dysbindin, a protein linked to schizophrenia. This phosphorylation reduces dysbindin stability and neurite outgrowth, offering new insights into neurodegenerative disease mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Vaccinia-related kinase 2 (VRK2) is a kinase implicated in neurodegenerative disorders like schizophrenia.
- Dysbindin is a known risk factor for schizophrenia, with reduced expression in patients and roles in neurite outgrowth and NMDA receptor signaling.
- The specific substrates and functions of VRK2 remain largely unknown.
Purpose of the Study:
- To identify novel interacting proteins of VRK2.
- To investigate whether VRK2 phosphorylates dysbindin and the functional consequences of this interaction.
- To explore the role of VRK2-dysbindin interaction in neuronal function relevant to schizophrenia.
Main Methods:
- Co-immunoprecipitation to identify VRK2-interacting proteins.
- In vitro kinase assays to determine VRK2 phosphorylation sites on dysbindin.
- Western blotting to assess ubiquitination and protein stability.
- Cell culture experiments (SH-SY5Y cells, mouse hippocampal neurons) to evaluate effects on neurite outgrowth and NMDA receptor subunit expression.
Main Results:
- Dysbindin was identified as a novel interacting protein of VRK2.
- VRK2 was shown to phosphorylate dysbindin at Serine 297 and Serine 299.
- VRK2-mediated phosphorylation enhanced dysbindin ubiquitination, decreasing its protein stability.
- Overexpression of VRK2 reduced retinoic acid-induced neurite outgrowth in SH-SY5Y cells.
- A phosphomimetic dysbindin mutant impaired neurite outgrowth and affected surface expression of N-methyl-D-aspartate 2A (a subunit of NMDA receptor).
Conclusions:
- This study reveals VRK2 as a regulator of dysbindin through phosphorylation.
- The findings elucidate a novel molecular mechanism linking VRK2 and dysbindin, both implicated in schizophrenia.
- This provides a foundation for understanding the pathogenesis of schizophrenia and developing therapeutic strategies.
More Related Videos
09:27Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins
Published on: January 17, 2014
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
RNA Stability